Logo_Interreg-Atlantic-Area_COLOR
  • neuroATLANTIC
  • Partners
  • News&Events
  • Contact
  • Results&Outputs
  • twitter
  • linkedin
  • Why joining neuroATLANTIC?

    The neuroATLANTIC network is mainly focused on early detection non-invasive techniques of Alzheimer and stroke. It is funded to promote research and access of companies to its results in order to develop new solutions to improve the lives of patients with neurological diseases.

    Fill in this form to become part of the neuroATLANTIC ecosystem (5 min)

    CSG is the partner in charge of capitilizing the neuroATLANTIC project. If you have any questions, please contact gestion@clustersaude.com

What is neuroATLANTIC?

Neurological diseases are disorders that affect the central nervous system and can impair the brain, spinal cord, peripheral nerve or neuromuscular function. Most of these diseases are directly related to ageing, with Alzheimer’s Disease (AD) and stroke being especially relevant due to their incidence and the economic burden they carry. More than 7.5 million European citizens aged between 30 and 99 years suffer from different types of dementia.

neuroATLANTIC project will contribute to address this challenge by proposing new standardized clinical protocols, innovative diagnostic and treatment methods and ensuring technology transfer to enterprises to favour the uptake of innovations in real settings. Specifically, neuroATLANTIC will act on the clinical, preclinical and capitalization aspects as following: 

  1. The project will explore best clinical practices to elaborate a “green paper” to propose an improved clinical management (diagnosis and treatment) of Alzheimer´s Disease and stroke patients. 
  2. neuroATLANTIC will set up a preclinical translational research platform with all the elements needed (animal models, nanostructures synthesis, assessment of exploitation potential, etc.) to bring innovative theragnostic agents and nanobiosensors (to be used to enhance diagnosis and treatment) to real settings. To test the translation platform feasibility, we will focus on two initial projects: biofunciontionalized nanostructures as contrast agents and nanobiosensors. These projects will give us useful insights to strengthen such platform in the future. 
  3. neuroATLANTIC will pay attention to capitalization of results: technology roadmap and exploitation plans will be delivered for the selected projects; a governance structure will be defined in order to select new projects to be developed in the platform and, finally, R&D mission-oriented guidelines will be developed in order to define a strategic R&D agenda to address neurological diseases in the future.

Download the neuroATLANTIC Dossier of capabilities to find out more

Video Title

News

  • Capitalization meeting in Basque Country
    02/12/2022
    neuroAtlantic capitalization meeting in Basque Country on November 10th, 2022 […]
  • Capitalization meeting in France
    29/06/2022
    On June 28th, 2022, the Cluster Saúde de Galicia, CSG, […]
  • Capitalization meeting in Northern Ireland
    28/05/2022
    Although the United Kingdom has been excluded from the […]
  • Capitalization meeting in Ireland
    13/05/2022
    On May 12th, 2022, the Cluster Saúde de Galicia, CSG, […]
  • Capitalization meeting in Portugal
    30/04/2022
    From 26 to 29 of April, 2022, the Cluster Saúde de […]
<< Feb 2023 >>
MTWTFSS
30 31 1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 1 2 3 4 5
Tweets by ClusterSaude
Leading Partner
Fundación Instituto de Investigación Sanitaria de Santiago de Compostela (FIDIS)

Fundación Instituto de Investigación Sanitaria de Santiago de Compostela (FIDIS)

Partners

Center for Cooperative Research in Biomaterials CICbiomaGUNE

Center for Cooperative Research in Biomaterials CICbiomaGUNE

Clúster Saúde de Galicia – CSG

Clúster Saúde de Galicia – CSG

Institut National de la Santé et de la Recherche Médicale (INSERM) Délégation Régionale Nord Ouest

Institut National de la Santé et de la Recherche Médicale (INSERM) Délégation Régionale Nord Ouest

LINCBIOTECH, SL

LINCBIOTECH, SL

QUBIOTECH HEALTH INTELLIGENCE SL

QUBIOTECH HEALTH INTELLIGENCE SL

STAB VIDA Investigaçao e Serviços em Ciencias Biológicas, Lda

STAB VIDA Investigaçao e Serviços em Ciencias Biológicas, Lda

Universidade de Coimbra Divisao de Apoio e Promoçao da Investigaçao

Universidade de Coimbra Divisao de Apoio e Promoçao da Investigaçao

University College Cork – National University of Ireland Office of the VicePresident for Research & Innovation

University College Cork – National University of Ireland Office of the VicePresident for Research & Innovation

Our location

Contact Form

neuroATLANTIC

Fundación Instituto de Investigación Sanitaria de Santiago de Compostela
Hospital Clínico, Edificio D, 1º Andar
Travesa da Choupana s/n. 15706 Santiago de Compostela
+34 981 950 418
contact@neuroatlantic.eu
idisantiago.es

 

Designed by: freepik.es

Esta web utiliza cookies, puedes ver aquí la Política de Cookies